Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-092157

Chief Development Officer acquired 996 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Grant or award : show line 1 in the form +498 $35.97 $17,913 1,733 D
2026-03-02 Grant or award : show line 2 in the form +498 2,231 D
Loading xslF345X05/ownership.xml…